Pharmacological characterisation of the relaxation induced by the soluble guanylate cyclase activator, BAY 60-2770 in rabbit corpus cavernosum

Oxidative stress associated with middle aging leads to sympathetic hyperactivity and downregulation of soluble guanylyl cyclase in corpus cavernosum

(2014) Fábio H. Silva et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Vascular oxidative stress, nitric oxide and atherosclerosis

(2014) Huige Li et al.   ATHEROSCLEROSIS

The sGC activator BAY 60-2770 has potent erectile activity in the rat

(2013) George F. Lasker et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Insights into BAY 60-2770 Activation and S-Nitrosylation-Dependent Desensitization of Soluble Guanylyl Cyclase via Crystal Structures of Homologous Nostoc H-NOX Domain Complexes

(2013) Vijay Kumar et al.   BIOCHEMISTRY

Arterial erectile dysfunction: Different severities of endothelial apoptosis between diabetic patients “responders” and “non responders” to sildenafil

(2013) Rosita A. Condorelli et al.   European Journal of Internal Medicine

Activation of Haem-Oxidized Soluble Guanylyl Cyclase with BAY 60-2770 in Human Platelets Lead to Overstimulation of the Cyclic GMP Signaling Pathway

(2012) Camila B. Mendes-Silverio et al.   PLoS One

Combination of BAY 60-4552 and Vardenafil Exerts Proerectile Facilitator Effects in Rats With Cavernous Nerve Injury: A Proof of Concept Study for the Treatment of Phosphodiesterase Type 5 Inhibitor Failure

(2011) Alexandra Oudot et al.   EUROPEAN UROLOGY

Assessment of the Effects of Renal Impairment on the Pharmacokinetics of the Soluble Guanylate Cyclase Activator Cinaciguat After a Single Intravenous Dose

(2011) John T. Lettieri et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Comparative Relaxing Effects of Sildenafil, Vardenafil, and Tadalafil in Human Corpus Cavernosum: Contribution of Endogenous Nitric Oxide Release

(2009) Haroldo A. Toque et al.   UROLOGY